Comments
Shares of Sequent Scientific fell nearly 3 per cent today after the Maharashtra Food and Drug Administration (FDA) has ordered suspension of manufacturing at the company's Mahad facility for 15 days, starting July 1.
The company's stock plummeted 2.57 per cent to settle at Rs 140.50 on the BSE. During the day, it dropped 6.38 per cent to Rs 135.
On the NSE, it declined by 2.58 per cent to close at Rs 141.20.
In a regulatory filing, the company said after inspection, FDA has passed an order to suspend the manufacturing licences at Mahad unit for 15 days, from July 1 to July 15, 2016.
“All of the procedural matters have been addressed by the company, and as a process, we have filed an appeal with the Minister for Health and Medical Education of Maharashtra for staying and subsequent revocation of this order,” Sequent Scientific said.
The company is hopeful of getting the process completed in the next couple of days, it added.
In the meantime, the unit continues to operate and the company expects no business interruptions, it said
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.